GASTROINTENSTINAL STROMAL TUMOR (GIST)
Clinical trials for GASTROINTENSTINAL STROMAL TUMOR (GIST) explained in plain language.
Never miss a new study
Get alerted when new GASTROINTENSTINAL STROMAL TUMOR (GIST) trials appear
Sign up with your email to follow new studies for GASTROINTENSTINAL STROMAL TUMOR (GIST), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Robot surgeons take on tricky stomach tumors in new safety trial
Disease control Recruiting nowThis study looks at how safe robotic surgery is for removing gastrointestinal stromal tumors (GISTs) that are in tricky spots in the stomach. About 182 people with small to medium-sized tumors (2 to 5 cm) will have the surgery and be watched for 3 years to see if the tumors come …
Matched conditions: GASTROINTENSTINAL STROMAL TUMOR (GIST)
Phase: NA • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated May 07, 2026 18:43 UTC
-
Living longer with GIST: what are the hidden costs?
Knowledge-focused Recruiting nowThis study follows 330 adults with advanced or metastatic GIST who have been on targeted therapy (TKIs) for at least two years. Researchers will track quality of life, treatment side effects, and financial challenges over up to 10 years. The goal is to better understand what long…
Matched conditions: GASTROINTENSTINAL STROMAL TUMOR (GIST)
Sponsor: The Netherlands Cancer Institute • Aim: Knowledge-focused
Last updated May 17, 2026 13:06 UTC